ARTICLE SUMMARY:
Cardiac monitoring for the detection of arrhythmias such as atrial fibrillation has evolved into a fragmented and complex market with embedded inefficiencies that make monitoring cumbersome and delay diagnosis. While medical device companies to date have focused on patient-worn or implanted monitoring components, InfoBionic believes it will disrupt the market with a focus on the back-end: the Cloud-based analytics and software.
In just two weeks, InfoBionic Inc. will commercialize a new HIPAA-co mpliant, Cloud-based cardiac monitoring platform for the detection of arrhythmias such as atrial fibrillation.
